Illumina Company Leadership

Illumina's latest congressional trading

Illumina Management Team Effectiveness

The company has return on total asset (ROA) of 0.0915 % which means that it generated a profit of $0.0915 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.312 %, meaning that it created $0.312 on every $100 dollars invested by stockholders. Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of January 2026, Return On Tangible Assets is likely to grow to -0.22. In addition to that, Return On Capital Employed is likely to grow to -0.11. At this time, Illumina's Fixed Asset Turnover is very stable compared to the past year. As of the 5th of January 2026, Common Stock Shares Outstanding is likely to drop to about 130.9 M. In addition to that, Net Loss is likely to grow to about (1 B)The majority of Illumina outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Illumina to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Illumina. Please pay attention to any change in the institutional holdings of Illumina as this could imply that something significant has changed or is about to change at the company. On April 21, 2025, Representative Thomas H Kean of US Congress acquired under $15k worth of Illumina's common stock. Some institutional investors establish a significant position in stocks such as Illumina in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Illumina, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Illumina Workforce Comparison

Illumina Profit Margins

The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.

Illumina Insider Trading History

Illumina Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Illumina often depends on how effective the management is. Illumina management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Illumina management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Illumina management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.